Therefore, Fra-1 inhibition might counteract the intrinsic or acquired melanoma resistance to BRAF and/or MEK inhibitors, by suppressing the ZEB1-regulated EMT-like transcriptional programs. This evidence concerns the gene ZEB1 and melanoma.